دورية أكاديمية
أعرض في EDS

Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes.

التفاصيل البيبلوغرافية
العنوان: Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes.
المؤلفون: Rinaldi B; Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Bayat A; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark.; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund 4293, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense 5230Denmark., Zachariassen LG; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Sun JH; State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Department of Neurology, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210032, China.; Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 310030, China., Ge YH; State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Department of Neurology, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210032, China.; Ministry of Education Key Laboratory of Model Animal for Disease Study, National Resource Center for Mutant Mice, Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210032, China., Zhao D; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Bonde K; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Madsen LH; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Awad IAA; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Bagiran D; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Sbeih A; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Shah SM; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., El-Sayed S; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Lyngby SM; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Pedersen MG; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Stenum-Berg C; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark., Walker LC; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1H 8M5, Canada., Krey I; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig 04103, Germany., Delahaye-Duriez A; Unité fonctionnelle de médecine génomique et génétique clinique, Hôpital Jean Verdier, Assistance Publique des Hôpitaux de Paris, Bondy 93140, France.; NeuroDiderot, UMR 1141, Inserm, Université Paris Cité, Paris 75019, France.; UFR SMBH, Université Sorbonne Paris Nord, Bobigny 93000, France., Emrick LT; Division of Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Sully K; Division of Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Murali CN; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Burrage LC; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Plaud Gonzalez JA; Division of Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Parnes M; Division of Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.; Pediatric Movement Disorders Clinic, Texas Children's Hospital and Baylor College of Medicine, Houston, TX 77030, USA., Friedman J; Rady Children's Institute for Genomic Medicine, San Diego, CA 92123, USA.; Department of Neurosciences, University of California San Diego, San Diego, CA 92123, USA.; Department of Pediatrics, University of California San Diego, San Diego, CA 92123, USA., Isidor B; Nantes Université, CHU Nantes, Service de Génétique Médicale, Nantes 44000, France., Lefranc J; Pediatric Neurophysiology Department, CHU de Brest, Brest 29200, France., Redon S; Service de Génétique Médicale, CHU de Brest, Brest 29200, France.; Université de Brest, CHU de Brest, UMR 1078, Brest F29200, France., Heron D; APHP Sorbonne Université, Département de Génétique, Hôpital Armand Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France.; Centre de Référence Déficiences Intellectuelles de Causes Rares, Paris 75013, France., Mignot C; APHP Sorbonne Université, Département de Génétique, Hôpital Armand Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France.; Centre de Référence Déficiences Intellectuelles de Causes Rares, Paris 75013, France., Keren B; Genetic Department, APHP, Sorbonne Université, Pitié-Salpêtrière Hospital, Paris 75013, France., Fradin M; Service de Génétique Médicale, Hôpital Sud, CHU de Rennes, Rennes 35200, France., Dubourg C; Service de Génétique Moléculaire et Génomique, CHU de Rennes, Rennes 35200, France.; Université de Rennes, CNRS, Institut de Genetique et Developpement de Rennes, UMR 6290, Rennes 35200, France., Mercier S; Nantes Université, CHU Nantes, Service de Génétique Médicale, Nantes 44000, France.; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes 44000, France., Besnard T; Nantes Université, CHU Nantes, Service de Génétique Médicale, Nantes 44000, France.; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes 44000, France., Cogne B; Nantes Université, CHU Nantes, Service de Génétique Médicale, Nantes 44000, France.; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes 44000, France., Deb W; Nantes Université, CHU Nantes, Service de Génétique Médicale, Nantes 44000, France.; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes 44000, France., Rivier C; Department of Paediatrics, Villefranche-sur-Saône Hospital, Villefranche-sur-Saône 69655, France., Milani D; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Bedeschi MF; Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Di Napoli C; Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Grilli F; Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Marchisio P; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Pediatria Pneumoinfettivologia, Milan 20122, Italy.; University of Milan, Milan 20122, Italy., Koudijs S; Department of Neurology, ENCORE, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam 3015, The Netherlands., Veenma D; Department of Pediatrics, ENCORE, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam 3015, The Netherlands., Argilli E; Institute of Human Genetics, University of California, San Francisco, CA 94143, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA 94143, USA., Lynch SA; Department of Clinical Genetics, Children's Health Ireland Crumlin, Dublin D12 N512, Ireland., Au PYB; Department of Medical Genetics, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., Ayala Valenzuela FE; Hospital Angeles Tijuana, Tijuana 22010, Mexico., Brown C; Illumina Inc, San Diego, CA 92122, USA., Masser-Frye D; Division of Genetics, Department of Pediatrics, UC San Diego School of Medicine, Rady Children's Hospital, San Diego, CA 92123, USA., Jones M; Division of Genetics, Department of Pediatrics, UC San Diego School of Medicine, Rady Children's Hospital, San Diego, CA 92123, USA., Patron Romero L; Facultad de Medicina y Psicología, Universidad Autónoma de Baja California, Tijuana 22010, Mexico., Li WL; Breakthrough Genomics Inc, Irvine, CA 92618, USA., Thorpe E; Illumina Inc, San Diego, CA 92122, USA., Hecher L; Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg 20215, Germany., Johannsen J; Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg 20215, Germany., Denecke J; Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg 20215, Germany., McNiven V; Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1E8, Canada.; Fred A Litwin Family Centre in Genetic Medicine, University Health Network and Mount Sinai Hospital, Toronto, ON M5G 2C4, Canada., Szuto A; Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1E8, Canada.; Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON M5G 1E8, Canada., Wakeling E; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK., Cruz V; DDC Clinic Center for Special Needs Children, Middlefield, OH 44062, USA., Sency V; DDC Clinic Center for Special Needs Children, Middlefield, OH 44062, USA., Wang H; DDC Clinic Center for Special Needs Children, Middlefield, OH 44062, USA., Piard J; Centre de Génétique Humaine, Centre Hospitalier Universitaire, Université de Franche-Comté, Besançon 25000, France.; UMR 1231 GAD, Inserm, Université de Bourgogne Franche-Comté, Dijon 21000, France., Kortüm F; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany., Herget T; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany., Bierhals T; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany., Condell A; Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Melbourne, Victoria 3052, Australia., Ben-Zeev B; Pediatric Neurology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan 52621, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv 4R73+8Q, Israel., Kaur S; Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Melbourne, Victoria 3052, Australia.; Department of Paediatrics, Melbourne Medical School, University of Melbourne, Melbourne, Victoria 3052, Australia., Christodoulou J; Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Melbourne, Victoria 3052, Australia.; Department of Paediatrics, Melbourne Medical School, University of Melbourne, Melbourne, Victoria 3052, Australia.; Discipline of Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, New South Wales 2050, Australia.; Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NewSouth Wales 2050, Australia., Piton A; Hôpitaux Universitaires de Strasbourg, Laboratoire de Diagnostic Génétique, Strasbourg 67000, France., Zweier C; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.; Department of Human Genetics, Inselspital Bern, University of Bern, Bern 3010, Switzerland., Kraus C; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany., Micalizzi A; Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy., Trivisano M; Neurology, Epilepsy and Movement Disorders, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network EpiCARE, Rome 00165, Italy., Specchio N; Neurology, Epilepsy and Movement Disorders, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network EpiCARE, Rome 00165, Italy., Lesca G; Department of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon 69100, France.; Pathophysiology and Genetics of Neuron and Muscle (PNMG), UCBL, CNRS UMR5261 - INSERM U1315, Lyon 69100, France., Møller RS; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund 4293, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense 5230Denmark., Tümer Z; Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark., Musgaard M; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1H 8M5, Canada., Gerard B; Laboratoires de diagnostic genetique, Institut de genetique Medicale d'Alsace, Hopitaux Universitaires de Strasbourg, Strasbourg 67000, France., Lemke JR; Center for Rare Diseases, University of Leipzig Medical Center, Leipzig 04103, Germany., Shi YS; State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Department of Neurology, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210032, China.; Ministry of Education Key Laboratory of Model Animal for Disease Study, National Resource Center for Mutant Mice, Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210032, China.; Guangdong Institute of Intelligence Science and Technology, Zhuhai 519031, China., Kristensen AS; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark.
المصدر: Brain : a journal of neurology [Brain] 2024 May 03; Vol. 147 (5), pp. 1837-1855.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Oxford University Press
Original Publication: London.
مواضيع طبية MeSH: Neurodevelopmental Disorders*/genetics , Receptors, AMPA*/genetics , Phenotype* , Loss of Function Mutation*/genetics , Gain of Function Mutation*/genetics, Humans ; Male ; Female ; Child ; Child, Preschool ; Adolescent ; Infant ; Adult ; Young Adult
مستخلص: AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors (AMPARs) mediate fast excitatory neurotransmission in the brain. AMPARs form by homo- or heteromeric assembly of subunits encoded by the GRIA1-GRIA4 genes, of which only GRIA3 is X-chromosomal. Increasing numbers of GRIA3 missense variants are reported in patients with neurodevelopmental disorders (NDD), but only a few have been examined functionally. Here, we evaluated the impact on AMPAR function of one frameshift and 43 rare missense GRIA3 variants identified in patients with NDD by electrophysiological assays. Thirty-one variants alter receptor function and show loss-of-function or gain-of-function properties, whereas 13 appeared neutral. We collected detailed clinical data from 25 patients (from 23 families) harbouring 17 of these variants. All patients had global developmental impairment, mostly moderate (9/25) or severe (12/25). Twelve patients had seizures, including focal motor (6/12), unknown onset motor (4/12), focal impaired awareness (1/12), (atypical) absence (2/12), myoclonic (5/12) and generalized tonic-clonic (1/12) or atonic (1/12) seizures. The epilepsy syndrome was classified as developmental and epileptic encephalopathy in eight patients, developmental encephalopathy without seizures in 13 patients, and intellectual disability with epilepsy in four patients. Limb muscular hypotonia was reported in 13/25, and hypertonia in 10/25. Movement disorders were reported in 14/25, with hyperekplexia or non-epileptic erratic myoclonus being the most prevalent feature (8/25). Correlating receptor functional phenotype with clinical features revealed clinical features for GRIA3-associated NDDs and distinct NDD phenotypes for loss-of-function and gain-of-function variants. Gain-of-function variants were associated with more severe outcomes: patients were younger at the time of seizure onset (median age: 1 month), hypertonic and more often had movement disorders, including hyperekplexia. Patients with loss-of-function variants were older at the time of seizure onset (median age: 16 months), hypotonic and had sleeping disturbances. Loss-of-function and gain-of-function variants were disease-causing in both sexes but affected males often carried de novo or hemizygous loss-of-function variants inherited from healthy mothers, whereas affected females had mostly de novo heterozygous gain-of-function variants.
(© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
References: Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18163-8. (PMID: 17989220)
Front Neurosci. 2019 Nov 08;13:1135. (PMID: 31780880)
Neuron. 1991 May;6(5):799-810. (PMID: 1673851)
Am J Hum Genet. 2009 Apr;84(4):524-33. (PMID: 19344873)
Nat Neurosci. 2003 Feb;6(2):136-43. (PMID: 12536214)
Hum Mutat. 2020 Feb;41(2):363-374. (PMID: 31782251)
Genet Med. 2019 Nov;21(11):2413-2421. (PMID: 31182824)
Nat Commun. 2019 Jul 12;10(1):3094. (PMID: 31300657)
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7557-61. (PMID: 1652753)
Mol Cell Neurosci. 2008 May;38(1):117-23. (PMID: 18395463)
Hum Genome Var. 2023 Feb 2;10(1):4. (PMID: 36726007)
Brain. 2017 Sep 1;140(9):2337-2354. (PMID: 29050392)
Eur J Hum Genet. 2010 Jan;18(1):39-46. (PMID: 19623214)
Hum Genet. 2022 Feb;141(2):283-293. (PMID: 35031858)
Front Genet. 2022 Apr 20;13:859140. (PMID: 35518358)
Hum Mutat. 2019 Sep;40(9):1330-1345. (PMID: 31144778)
Neuron. 2018 Sep 5;99(5):956-968.e4. (PMID: 30122377)
Brain. 2017 May 1;140(5):1316-1336. (PMID: 28379373)
Genomics. 1999 Dec 15;62(3):356-68. (PMID: 10644433)
Nat Neurosci. 2017 Aug;20(8):1043-1051. (PMID: 28628100)
Curr Drug Targets. 2007 May;8(5):583-602. (PMID: 17504103)
Brain. 2019 Jan 1;142(1):80-92. (PMID: 30544257)
Cells. 2022 Nov 17;11(22):. (PMID: 36429079)
Biochemistry. 2007 Feb 20;46(7):2027-36. (PMID: 17256974)
J Neurophysiol. 1995 Jul;74(1):218-25. (PMID: 7472325)
Science. 2000 Mar 24;287(5461):2262-7. (PMID: 10731148)
J Hum Genet. 2021 Mar;66(3):339-343. (PMID: 32948840)
Epilepsia. 2022 Dec;63(12):e156-e163. (PMID: 36161652)
Neuron. 2009 Feb 12;61(3):340-50. (PMID: 19217372)
ACS Med Chem Lett. 2018 Oct 16;10(3):237-242. (PMID: 30891119)
PLoS One. 2017 Feb 2;12(2):e0170843. (PMID: 28152038)
Hum Mol Genet. 2017 Oct 15;26(20):3869-3882. (PMID: 29016847)
PLoS Genet. 2021 Jun 23;17(6):e1009608. (PMID: 34161333)
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Aug 10;36(8):829-833. (PMID: 31400139)
Brain. 2023 Mar 1;146(3):923-934. (PMID: 36036558)
Cold Spring Harb Mol Case Stud. 2022 May 9;:. (PMID: 35534222)
JAMA. 2014 Nov 12;312(18):1870-9. (PMID: 25326635)
Epileptic Disord. 2022 Oct 1;24(5):765-786. (PMID: 35830287)
Neuron. 1992 Jul;9(1):173-86. (PMID: 1352983)
Mol Psychiatry. 2016 Jan;21(1):133-48. (PMID: 25644381)
Am J Med Genet A. 2007 Jul 1;143A(13):1448-55. (PMID: 17568425)
Neuropsychopharmacology. 2008 Feb;33(3):465-72. (PMID: 17487227)
Epilepsia. 2016 Jan;57(1):e12-7. (PMID: 26648591)
Orphanet J Rare Dis. 2014 Apr 11;9:49. (PMID: 24721225)
Science. 2019 Apr 26;364(6438):355-362. (PMID: 30975770)
Seizure. 2020 Nov;82:1-6. (PMID: 32977175)
Am J Med Genet A. 2013 Jun;161A(6):1370-5. (PMID: 23637084)
Science. 1990 Aug 3;249(4968):556-60. (PMID: 2166337)
Science. 1997 Jun 27;276(5321):2042-5. (PMID: 9197267)
J Neurosci. 1996 Mar 15;16(6):1982-9. (PMID: 8604042)
J Pharmacol Exp Ther. 2022 Apr;381(1):54-66. (PMID: 35110392)
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1443-7. (PMID: 1311100)
Eur J Med Genet. 2022 Mar;65(3):104442. (PMID: 35093607)
Arch Gen Psychiatry. 2009 Sep;66(9):947-56. (PMID: 19736351)
Nat Commun. 2022 Apr 5;13(1):1822. (PMID: 35383156)
Science. 2005 Apr 1;308(5718):83-8. (PMID: 15746389)
Mov Disord Clin Pract. 2023 Jun 12;10(8):1222-1224. (PMID: 37635778)
Brain. 2022 Sep 14;145(9):2991-3009. (PMID: 34431999)
Nature. 1992 Jan 9;355(6356):163-6. (PMID: 1370344)
Neuropharmacology. 2021 Nov 1;199:108805. (PMID: 34560056)
J Physiol. 1997 Dec 15;505 ( Pt 3):655-63. (PMID: 9457643)
J Med Genet. 2006 Nov;43(11):843-9. (PMID: 16840569)
Eur J Hum Genet. 2013 Jan;21(1):112-4. (PMID: 22669415)
Am J Hum Genet. 2022 Jul 7;109(7):1217-1241. (PMID: 35675825)
J Physiol. 2021 May;599(10):2639-2653. (PMID: 32749711)
Neuron. 1988 Dec;1(10):911-7. (PMID: 2908443)
Neurosci Lett. 1986 Jan 30;63(3):225-30. (PMID: 2869459)
Mol Psychiatry. 2022 Oct;27(10):4092-4102. (PMID: 35697757)
Nature. 1998 Aug 13;394(6694):683-7. (PMID: 9716132)
Nat Toxins. 1998;6(3-4):153-8. (PMID: 10223631)
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):257-260. (PMID: 29653005)
Neuron. 1998 Oct;21(4):907-18. (PMID: 9808475)
Mov Disord. 2020 Jul;35(7):1224-1232. (PMID: 32369665)
Epilepsy Res. 2018 Aug;144:53-61. (PMID: 29778030)
Science. 1990 Sep 28;249(4976):1580-5. (PMID: 1699275)
Neuron. 2014 Oct 01;84(1):41-54. (PMID: 25242221)
Cell. 2003 Mar 7;112(5):631-43. (PMID: 12628184)
Cell. 2007 Oct 5;131(1):160-73. (PMID: 17923095)
Clin Genet. 2018 Mar;93(3):567-576. (PMID: 28708303)
J Neurosci. 1996 Dec 1;16(23):7496-504. (PMID: 8922405)
Hum Mutat. 2015 Oct;36(10):928-30. (PMID: 26220891)
Epilepsia. 2020 Mar;61(3):387-399. (PMID: 32090326)
Neuron. 2011 Apr 28;70(2):178-99. (PMID: 21521608)
Trends Neurosci. 2006 Oct;29(10):554-62. (PMID: 16890999)
Neurosci Res. 1997 Sep;29(1):27-36. (PMID: 9293490)
Am J Hum Genet. 2017 Dec 7;101(6):1013-1020. (PMID: 29220673)
Genet Med. 2020 Jul;22(7):1156-1174. (PMID: 32284538)
J Physiol. 1990 Nov;430:605-16. (PMID: 1982315)
BMC Pediatr. 2022 Nov 3;22(1):629. (PMID: 36329391)
Science. 1990 Aug 31;249(4972):1033-7. (PMID: 2168579)
Nature. 1989 Dec 7;342(6250):643-8. (PMID: 2480522)
J Neurosci. 1997 Jan 1;17(1):58-69. (PMID: 8987736)
Aviat Space Environ Med. 2007 Oct;78(10):937-43. (PMID: 17955941)
J Am Chem Soc. 2019 Feb 6;141(5):1798-1806. (PMID: 30532973)
Am J Med Genet A. 2009 Jun;149A(6):1280-9. (PMID: 19449417)
Epilepsia. 2019 Mar;60 Suppl 1:22-36. (PMID: 29953584)
Neuron. 2012 May 24;74(4):621-33. (PMID: 22632720)
Neurogenetics. 2022 Jan;23(1):27-35. (PMID: 34731330)
Eur Neuropsychopharmacol. 1991 Dec;1(4):511-7. (PMID: 1822317)
Genome Res. 2017 Oct;27(10):1715-1729. (PMID: 28864458)
Nucleic Acids Res. 2019 Jul 2;47(W1):W121-W126. (PMID: 31170280)
Neurol Genet. 2020 Nov 30;6(6):e528. (PMID: 33659638)
Pharmacol Rev. 2021 Oct;73(4):298-487. (PMID: 34753794)
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. (PMID: 29165669)
معلومات مُعتمدة: U54 OD030165 United States OD NIH HHS; 5U54OD030165 United States NH NIH HHS
فهرسة مساهمة: Keywords: AMPA receptor; GRIA; GRIA3; clinical biomarker; genotype-phenotype
المشرفين على المادة: 0 (Receptors, AMPA)
0 (glutamate receptor ionotropic, AMPA 3)
تواريخ الأحداث: Date Created: 20231201 Date Completed: 20240503 Latest Revision: 20240507
رمز التحديث: 20240507
مُعرف محوري في PubMed: PMC11068105
DOI: 10.1093/brain/awad403
PMID: 38038360
قاعدة البيانات: MEDLINE
الوصف
تدمد:1460-2156
DOI:10.1093/brain/awad403